World Bank approves $114 mln for Nigeria's COVID-19 response

Published 07/08/2020, 15:27
Updated 07/08/2020, 15:30
© Reuters.

ABUJA, Aug 7 (Reuters) - The World Bank has approved $114
million to help Nigeria tackle its coronavirus pandemic, the
global lender said on Friday.
The money comes in the form of a $100 million loan and a $14
million grant to be split between Nigeria's 36 states and
federal-level procurement of medical equipment, tests and
medicine.
Africa's most populous country has recorded more than 45,000
confirmed coronavirus cases and 930 deaths, but low levels of
testing have left a muddy picture of the outbreak's severity.
"Nigeria has ramped up its efforts to contain the COVID-19
outbreak, but more needs to done at the state level, which are
at the front line of the response," Shubham Chaudhuri, the World
Bank's director for Nigeria, said in its statement on Friday.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.